- AstraZeneca’s $1.3B bet reduces blood pressure by 14 mmHg over 12 weeks in phase 3 win Fierce Biotech
- Astrazeneca Says Hypertension Drug Meets Main, Secondary Goals in Phase 3 Study MarketScreener
- Baxdrostat demonstrated a statistically…
Category: 6. Health
-
AstraZeneca's $1.3B bet reduces blood pressure by 14 mmHg over 12 weeks in phase 3 win – Fierce Biotech
-
Genetic and cellular mechanisms underlying steatotic liver disease
Steatotic liver disease (SLD), mainly encompassing metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), and metabolic dysfunction and ALD (MetALD), has emerged as the dominant…
Continue Reading
-
Antibody from Tanzanian woman suppresses almost all tested HIV variants including resistant viruses in pre-clinical study
An antibody from a Tanzanian woman discovered during screening for anti-HIV antibodies shows a strong therapeutic potential in a preclinical study. Named 04_A06, it neutralised (blocked) 97.3% of over 300 HIV strains tested, and blocked 77% of…
Continue Reading
-
Research cautions that ignoring calorie reductions on intermittent fasting reduces benefits
Without changing a person’s caloric intake, intermittent fasting does not lead to measurable metabolic or cardiovascular improvements, according to new research. The study focused on time-restricted eating (TRE), a form of intermittent fasting…
Continue Reading
-
GLP-1 weight loss drugs may protect against pancreatitis
A new study has found that GLP-1 weight loss drugs do not increase the risk of pancreatitis or heart problems in patients with high triglycerides – and may even help protect against the condition.
A new study from Intermountain…
Continue Reading
-
A plain language summary of the CEPHEUS study: D-VRd for newly diagnosed multiple myeloma patients who are not expected to receive a stem cell transplant
The CEPHEUS study evaluated the effectiveness of adding daratumumab to the standard VRd regimen (bortezomib, lenalidomide, and dexamethasone) in newly diagnosed multiple myeloma patients ineligible for transplant. Read more about the…
Continue Reading
-
Coffee may protect people against irregular heartbeats, new US study finds | US news
Drinking coffee may protect people against irregular heartbeats, despite the conventional wisdom to the contrary, according to a new study.
The Does Eliminating Coffee Avoid Fibrillation (Decaf) clinical trial found 200 patients with persistent…
Continue Reading
-
New whooping cough vaccine could transform respiratory disease treatment
Researchers at Trinity have developed a new platform for vaccine delivery they say could revolutionise treatment for respiratory infections.
Whooping cough (also known as pertussis) is a highly contagious…
Continue Reading
-
diet advice and family support can lower blood pressure
NEW ORLEANS — A record-breaking 4,432 scientific abstracts accepted at the American Heart Association’s meeting here adorned posters, animated panel discussions, or drew crowds to massive halls. They promised innovations in understanding and…
Continue Reading
-
Common Medications May Harm Breast Cancer Outcomes
A major international study involving 23,000 people has found concerning evidence about the impact of a range of common, everyday medications on the treatment outcomes for patients with breast cancer.
Led by the University of South…
Continue Reading